Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Heron Therapeutics, Inc.(HRTX) | 6,986,744 | 6,986,744 | 0 | $10.69M | $15.37M | 15.81% | +$4.68M |
| Acelyrin Inc | 0 | 3,366,945 | +3,366,945 | $0 | $8.32M | 8.56% | +$8.32M |
| Springworks Therapeutics Inc | 185,520 | 185,520 | 0 | $6.70M | $8.19M | 8.42% | +$1.48M |
| Protara Therapeutics, Inc.(TARA) | 1,579,000 | 1,667,800 | +88,800 | $8.34M | $7.10M | 7.31% | -$1.23M |
| Praxis Precision Medicines, Inc.(PRAX) | 300,000 | 185,000 | -115,000 | $23.09M | $7.01M | 7.21% | -$16.08M |
| Tourmaline Bio Inc | 423,795 | 455,412 | +31,617 | $8.59M | $6.93M | 7.13% | -$1.67M |
| Jasper Therapeutics, Inc.(JSPR) | 1,433,828 | 1,433,828 | 0 | $30.66M | $6.17M | 6.34% | -$24.49M |
| Verona Pharma PlcADS | 50,000 | 95,000 | +45,000 | $2.32M | $6.03M | 6.20% | +$3.71M |
| Zevra Therapeutics, Inc.(ZVRA) | 300,000 | 665,000 | +365,000 | $2.50M | $4.98M | 5.12% | +$2.48M |
| Liquidia Corporation(LQDA) | 300,000 | 300,000 | 0 | $3.53M | $4.42M | 4.55% | +$897.0K |
| InspireMD, Inc.(NSPR) | 904,029 | 904,029 | 0 | $2.38M | $2.43M | 2.50% | +$54.2K |
| Scpharmaceuticals Inc | 0 | 917,668 | +917,668 | $0 | $2.41M | 2.48% | +$2.41M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 150,600 | +150,600 | $0 | $2.39M | 2.46% | +$2.39M |
| Replimune Group, Inc.(REPL) | 181,367 | 182,083 | +716 | $2.20M | $1.78M | 1.83% | -$421.0K |
| Edesa Biotech, Inc.(EDSA) | 0 | 687,500 | +687,500 | $0 | $1.68M | 1.73% | +$1.68M |
| Instil Bio, Inc.(TIL) | 0 | 69,000 | +69,000 | $0 | $1.20M | 1.23% | +$1.20M |
| Rezolute, Inc.(RZLT) | 800,000 | 400,000 | -400,000 | $3.92M | $1.16M | 1.19% | -$2.76M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 323,973 | 323,973 | 0 | $1.33M | $1.10M | 1.13% | -$236.5K |
| Perspective Therapeutics, Inc.(CATX) | 500,000 | 500,000 | 0 | $1.59M | $1.06M | 1.10% | -$530.0K |
| Geron Corporation(GERN) | 49,000 | 655,000 | +606,000 | $173.5K | $1.04M | 1.07% | +$868.0K |
| Immunome, Inc.(IMNM) | 0 | 153,500 | +153,500 | $0 | $1.03M | 1.06% | +$1.03M |
| TELA Bio, Inc.(TELA) | 0 | 747,410 | +747,410 | $0 | $911.8K | 0.94% | +$911.8K |
| Avalo Therapeutics, Inc.(AVTX) | 109,972 | 111,972 | +2,000 | $817.1K | $896.9K | 0.92% | +$79.8K |
| Sutro Biopharma, Inc.(STRO) | 30,000 | 1,030,000 | +1,000,000 | $55.2K | $670.1K | 0.69% | +$614.9K |
| Upstream Bio, Inc.(UPB) | 0 | 107,000 | +107,000 | $0 | $654.8K | 0.67% | +$654.8K |
| Tenax Therapeutics, Inc.(TENX) | 83,333 | 83,333 | 0 | $515.8K | $545.8K | 0.56% | +$30.0K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 122,223 | 122,223 | 0 | $403.3K | $367.9K | 0.38% | -$35.4K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 56,700 | 59,000 | +2,300 | $669.1K | $313.3K | 0.32% | -$355.8K |
| Regulus Therapeutics Inc | 70,000 | 80,000 | +10,000 | $110.6K | $140.0K | 0.14% | +$29.4K |
| Wave Life Sciences, Inc.SHS(WVE) | 13,000 | 13,000 | 0 | $160.8K | $105.0K | 0.11% | -$55.8K |
| Gossamer Bio, Inc.(GOSS) | 75,000 | 75,000 | 0 | $67.8K | $82.5K | 0.08% | +$14.7K |
| Erasca, Inc.(ERAS) | 0 | 50,000 | +50,000 | $0 | $68.5K | 0.07% | +$68.5K |
| Alector Inc | 55,000 | 55,000 | 0 | $104.0K | $67.7K | 0.07% | -$36.3K |
| Larimar Therapeutics, Inc.(LRMR) | 18,000 | 28,000 | +10,000 | $69.7K | $60.2K | 0.06% | -$9.5K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 40,500 | 45,000 | +4,500 | $107.3K | $59.9K | 0.06% | -$47.5K |
| Context Therapeutics Inc.(CNTX) | 90,000 | 90,000 | 0 | $94.5K | $55.1K | 0.06% | -$39.4K |
| Design Therapeutics, Inc.(DSGN) | 0 | 14,000 | +14,000 | $0 | $54.0K | 0.06% | +$54.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 27,000 | 35,000 | +8,000 | $67.0K | $53.5K | 0.06% | -$13.4K |
| CytomX Therapeutics, Inc.(CTMX) | 35,000 | 75,000 | +40,000 | $36.0K | $47.7K | 0.05% | +$11.6K |
| Terns Pharmaceuticals Inc | 17,000 | 17,000 | 0 | $94.2K | $46.9K | 0.05% | -$47.3K |
| Ventyx Biosciences Inc | 35,000 | 40,000 | +5,000 | $76.7K | $46.0K | 0.05% | -$30.6K |
| 4d Molecular Therapeutics In | 10,000 | 12,000 | +2,000 | $55.7K | $38.8K | 0.04% | -$16.9K |
| PMV Pharmaceuticals, Inc.(PMVP) | 35,000 | 35,000 | 0 | $52.9K | $38.1K | 0.04% | -$14.7K |
| Ovid Therapeutics Inc.(OVID) | 70,000 | 97,000 | +27,000 | $65.4K | $30.3K | 0.03% | -$35.1K |
| Kronos Bio Inc | 35,000 | 35,000 | 0 | $33.3K | $28.9K | 0.03% | -$4.4K |
| Nextcure Inc | 25,000 | 25,000 | 0 | $19.3K | $12.0K | 0.01% | -$7.3K |
| Elevation Oncology Inc | 45,000 | 45,000 | 0 | $25.3K | $11.7K | 0.01% | -$13.7K |
| Bolt Biotherapeutics Inc | 50,000 | 0 | -50,000 | $26.8K | $0 | — | -$26.8K |
| Cocrystal Pharma, Inc.(COCP) | 10,000 | 0 | -10,000 | $20.2K | $0 | — | -$20.2K |
| Collegium Pharmaceutical, Inc.(COLL) | 28,685 | 0 | -28,685 | $821.8K | $0 | — | -$821.8K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 13,000 | 0 | -13,000 | $74.8K | $0 | — | -$74.8K |
| Fibrogen Inc | 80,000 | 0 | -80,000 | $42.4K | $0 | — | -$42.4K |
| Karyopharm Therapeutics Inc.(KPTI) | 40,000 | 0 | -40,000 | $27.1K | $0 | — | -$27.1K |
| Kura Oncology, Inc.(KURA) | 150,000 | 0 | -150,000 | $1.31M | $0 | — | -$1.31M |
| Nurix Therapeutics, Inc.(NRIX) | 97,889 | 0 | -97,889 | $1.84M | $0 | — | -$1.84M |